677 related articles for article (PubMed ID: 25453978)
1. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.
Sitticharoon C; Nway NC; Chatree S; Churintaraphan M; Boonpuan P; Maikaew P
Peptides; 2014 Dec; 62():164-75. PubMed ID: 25453978
[TBL] [Abstract][Full Text] [Related]
2. Correlations between the expression of the insulin sensitizing hormones, adiponectin, visfatin, and omentin, and the appetite regulatory hormone, neuropeptide Y and its receptors in subcutaneous and visceral adipose tissues.
Nway NC; Sitticharoon C; Chatree S; Maikaew P
Obes Res Clin Pract; 2016; 10(3):256-63. PubMed ID: 26067914
[TBL] [Abstract][Full Text] [Related]
3. Placental expressions and serum levels of adiponectin, visfatin, and omentin in GDM.
Souvannavong-Vilivong X; Sitticharoon C; Klinjampa R; Keadkraichaiwat I; Sripong C; Chatree S; Sririwichitchai R; Lertbunnaphong T
Acta Diabetol; 2019 Oct; 56(10):1121-1131. PubMed ID: 31076892
[TBL] [Abstract][Full Text] [Related]
4. The relation of omentin gene expression and glucose homeostasis of visceral and subcutaneous adipose tissues in non-diabetic adults.
Daneshafrooz A; Yuzbashian E; Zarkesh M; Asghari G; Mirmiran P; Hedayati M; Abooshahab R; Fanaei SM; Khalaj A
Mol Biol Rep; 2022 Jan; 49(1):163-169. PubMed ID: 34739694
[TBL] [Abstract][Full Text] [Related]
5. Low omentin-1 levels are related with clinical and metabolic parameters in obese children.
Catli G; Anik A; Abaci A; Kume T; Bober E
Exp Clin Endocrinol Diabetes; 2013 Nov; 121(10):595-600. PubMed ID: 24085389
[TBL] [Abstract][Full Text] [Related]
6. Omentin plasma levels and gene expression are decreased in obesity.
de Souza Batista CM; Yang RZ; Lee MJ; Glynn NM; Yu DZ; Pray J; Ndubuizu K; Patil S; Schwartz A; Kligman M; Fried SK; Gong DW; Shuldiner AR; Pollin TI; McLenithan JC
Diabetes; 2007 Jun; 56(6):1655-61. PubMed ID: 17329619
[TBL] [Abstract][Full Text] [Related]
7. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
Cai RC; Wei L; DI JZ; Yu HY; Bao YQ; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):381-4. PubMed ID: 19567114
[TBL] [Abstract][Full Text] [Related]
8. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
[TBL] [Abstract][Full Text] [Related]
9. Omentin-1, visfatin and adiponectin levels in relation to bone mineral density in Iranian postmenopausal women.
Tohidi M; Akbarzadeh S; Larijani B; Kalantarhormozi M; Ostovar A; Assadi M; Vahdat K; Farrokhnia M; Sanjdideh Z; Amirinejad R; Nabipour I
Bone; 2012 Nov; 51(5):876-81. PubMed ID: 22971441
[TBL] [Abstract][Full Text] [Related]
10. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study.
Herder C; Ouwens DM; Carstensen M; Kowall B; Huth C; Meisinger C; Rathmann W; Roden M; Thorand B
Eur J Endocrinol; 2015 Apr; 172(4):423-32. PubMed ID: 25733068
[TBL] [Abstract][Full Text] [Related]
12. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of adipokines, adiponectin, visfatin, and omentin, in uncomplicated type I diabetes patients before and after treatment of diabetic ketoacidosis.
Kalantarhormozi M; Jouyan N; Asadipooya K; Nabipour I; Mirzaei K
J Endocrinol Invest; 2020 Dec; 43(12):1723-1727. PubMed ID: 32342445
[TBL] [Abstract][Full Text] [Related]
14. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.
Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420
[TBL] [Abstract][Full Text] [Related]
15. Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome.
Orlik B; Madej P; Owczarek A; Skałba P; Chudek J; Olszanecka-Glinianowicz M
Clin Endocrinol (Oxf); 2014 Oct; 81(4):529-35. PubMed ID: 24392647
[TBL] [Abstract][Full Text] [Related]
16. Expressions of neuropeptide Y and Y1 receptor in subcutaneous and visceral fat tissues in normal weight and obese humans and their correlations with clinical parameters and peripheral metabolic factors.
Sitticharoon C; Chatree S; Churintaraphan M
Regul Pept; 2013 Aug; 185():65-72. PubMed ID: 23838112
[TBL] [Abstract][Full Text] [Related]
17. Variation in blood levels of hormones in obese patients following weight reduction induced by endoscopic and surgical bariatric therapies.
Wroblewski E; Swidnicka-Siergiejko A; Hady HR; Luba M; Konopko M; Kurek K; Dadan J; Dabrowski A
Cytokine; 2016 Jan; 77():56-62. PubMed ID: 26539806
[TBL] [Abstract][Full Text] [Related]
18. Body fat distribution has no effect on serum visfatin levels in healthy female subjects.
Ersoy C; Sadikoglu G; Orhan H; Guclu M; Sarandol E; Akgun MD; Ozcakir A; Imamoglu S
Cytokine; 2010 Mar; 49(3):275-8. PubMed ID: 20045351
[TBL] [Abstract][Full Text] [Related]
19. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.
Berndt J; Klöting N; Kralisch S; Kovacs P; Fasshauer M; Schön MR; Stumvoll M; Blüher M
Diabetes; 2005 Oct; 54(10):2911-6. PubMed ID: 16186392
[TBL] [Abstract][Full Text] [Related]
20. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome.
Jialal I; Devaraj S; Kaur H; Adams-Huet B; Bremer AA
J Clin Endocrinol Metab; 2013 Mar; 98(3):E514-7. PubMed ID: 23303213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
